China’s rapid rise in scientific research and innovation is reshaping global competition in technology, while India faces mounting pressure to significantly expand its own research and development (R&D) ecosystem, according to an analytical report. The commentary highlights how China is transitioning from large-scale manufacturing dominance to original scientific innovation, while India continues to lag in investment and institutional support for research despite strong talent output.
Recent developments underscore China’s technological ambitions. In Beijing, more than 300 humanoid robots participated in a half-marathon, with one robot developed by Honor reportedly outperforming top human runners in its category. Shortly after, Chinese President Xi Jinping attended a symposium in Shanghai, reinforcing his push to shift the country’s focus from “Made in China” to “Discovered in China,” signalling an emphasis on original innovation rather than imitation or scale-based production.
The report notes that China has made significant gains in global research output and funding. In 2024, it is said to have invested over $1 trillion in R&D (adjusted for purchasing power parity), surpassing the United States for the first time in this metric. China now accounts for a major share of global chemistry patent publications and has reportedly overtaken the US in areas such as cancer research output and total scientific publications, reflecting a broad-based expansion of its scientific ecosystem.
Also Read: PM Modi Highlights India’s Transition To Pharma Innovation Hub Driven By R&D
In contrast, the United States—long the global leader in research—is described as facing structural pressures. While it continues to benefit from strong universities, private capital, and global talent inflows, the report argues that corporate R&D has become more inward-looking compared to earlier decades. It also suggests that immigration restrictions and reduced education funding under President Donald Trump have weakened America’s traditional advantage in attracting global researchers and sustaining open scientific collaboration.
India’s challenge, however, is framed not in terms of talent but in investment and infrastructure. The country spends around 0.64% of its GDP on R&D, significantly lower than countries like South Korea, the US, and China. While India ranks high in scientific publications and has achieved notable milestones such as low-cost space missions, the report argues that limited funding, weak private sector participation, and underdeveloped research infrastructure continue to constrain long-term scientific progress.
Experts cited in the analysis emphasise that sustained investment in R&D creates compounding benefits across generations, driving innovation in areas such as healthcare, agriculture, climate science, and nutrition. The report concludes that India must urgently strengthen its research ecosystem—through higher funding, better industry-academia collaboration, and improved institutional support—or risk becoming a global talent supplier without building its own innovation leadership in the decades ahead.
Also Read: China Sentences Former Defence Ministers To Death With Reprieve Over Bribery Charges